Edition:
United States

Annidis Corp (RHA.V)

RHA.V on TSX Venture Exchange

0.02CAD
1 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,399
52-wk High
$0.09
52-wk Low
$0.01

Summary

Name Age Since Current Position

Gerald Slemko

61 2015 Chairman of the Board

Cameron Bramwell

2016 President, Chief Executive Officer

Brian Baker

2011 Chief Financial Officer

Michael Crowley

2016 Director

Zeljko Ribaric

2016 Director

Ying Zhi Gu

Independent Director

Chunhang Yu

Independent Director

Jinsong Zhang

Independent Director

Biographies

Name Description

Gerald Slemko

Mr. Gerald Slemko is Chairman of the Board of the Company. He was Chief Executive Officer, Director of Annidis Corporation. Mr. Slemko is currently CEO of Annidis as well as Managing Partner of Chelsey Corporation, a private investment management company. He is on the board of Ellis Don Limited (and Chair of the Audit Committee), one of Canada’s largest construction companies, Trudell Medical Limited, as well as numerous other private company boards in various industries. Mr. Slemko has been active in funding and providing management to numerous start-up companies. He is also President and CEO of Cuddy Corporation, which was formerly a major international poultry producer with sales in excess of $400 million, 2300 employees and operations in Canada, the US, Germany and Turkey. Prior to joining Cuddy Corporation Mr. Slemko was CEO and a founder of Oracle the Assistance Group, which was the leading provider of private label roadside assistance programs and nurse provided telehealth services in Canada. Mr. Slemko graduated from the Richard Ivey School of Business with an HBA. He began his career with PricewaterhouseCoopers, and obtained his CA with honours.

Cameron Bramwell

Mr. Cameron Bramwell is President, Chief Executive Officer of the company. He brings over 25 years of experience in the technology industry to Annidis. He has expertise in the leadership of both software and hardware companies operating in business to business marketplaces. In addition to his expertise as a marketing strategy consultant, Mr. Bramwell will draw from his recent experiences as chief marketing officer of StarTech.com, as well as president and CEO of Adlib Software. Mr. Bramwell has extensive experience piloting growth, in various stages of technology companies from inception through to maturity. In addition to his entrepreneurial and technology growth experience, Mr. Bramwell brings a wealth of international business, marketing strategy and general management experience. Mr. Bramwell graduated from the University of Western Ontario in London, Ont., with a bachelor of science in biology and a master of business administration from the Richard Ivey School of Business at University of Western Ontario where he graduated as an Ivey scholar.

Brian Baker

Michael Crowley

Mr. Michael Francis Crowley is Director of Annidis Corporation. Mr. Crowley is President of 108 Securities Inc., a boutique investment bank, which focuses on emerging private and public growth businesses and private equity succession MBO’s. In addition, Mr. Crowley is the co-founder and Managing Partner of Cassandra Capital L.P., a private, microcap venture capital fund established in 2007. Mr. Crowley managed a diversified portfolio of commercial and corporate banking clients in the early part of his career at a schedule A bank. During the last 12 years he has been actively involved in all aspects of the formation, management and financing of numerous technology start-up companies. During his 8 year tenure as VP Business Development with Robarts Research Institute, he created a company venture portfolio that attracted over $100 million in capital, and a technology license royalty portfolio which ranks among the top 3 performers in Canada. Mr. Crowley has completed a variety of financings and advisory engagements through his tenure at two IIROC firms and serves as a director for a number of private companies. Mr. Crowley received a BSc (biology) from the University of Western Ontario, an MBA from McMaster University, and is a Chartered Financial Analyst (CFA).

Zeljko Ribaric

Mr. Zeljko Ribaric is Director of Annidis Corporation. Mr. Ribaric was one of the founders of Annidis and has been actively involved in developing Annidis since 2005. He is an entrepreneur with over 20 years’ experience focused on commercializing complex technology products and services. Mr. Ribaric’s personal quest for solutions to detect and manage ocular disease has become his professional mission at Annidis. Through his progressive career in high tech companies in Canada he has played roles ranging from an electronics applications engineer, patent engineer to VP Business Development and Chief Executive Officer. Some of the companies he worked at include: Semiconductor Insights, CANAsic, ESP, and Photonics Control. Prior to starting Annidis, from 2000 to 2004, Mr. Ribaric started a leading edge system-on-a-chip company called Photonics Control in Ottawa, Canada where he played a key role in raising venture capital and help grow the company to 50 employees. During the past 10 years he has launched and led companies in the chip design, telecommunications and medical technology sector.

Ying Zhi Gu

Ms. Ying Zhi Gu is the Independent Director of the Company.Ms.Ying has been working in the ophthalmology industry for 20 years. Between 2002 and 2008, Ms. Gu was an independent director for LaserSight, Inc., a public company listed on the NASDAQ which manufactured and distributed equipment for the ophthalmology industry. In 2006, Ms. Gu co-founded Shenzen New Industries Material of Ophthalmology Co. Ltd. (“SZNIMO”) with Jinsong Zhang and Chunhang Yu and has worked in business development for SZNIMO since that time. Ms. Gu obtained an MBA from New York University.

Chunhang Yu

Jinsong Zhang

Mr.Jinsong Zhang is the Independent Director of the company. Mr.Jinsong Zhang worked for an investment holding company before he started working in the ophthalmology industry in 2002. In 2006, Mr. Zhang co-founded SZNIMO with Ying Zhi Gu and Chunhang Yu. SZNIMO specializes in the distribution of ophthalmology products in China and is the parent company of Yimai. Over the years, Mr. Zhang has built up a strong professional team in marketing, selling, training and development in the ophthalmology industry and has established a successful track record. Mr. Zhang currently resides in China.

Basic Compensation